Pete Stavropoulos
Stock Analyst at Cantor Fitzgerald
(0)
# 4476
Out of 5,347 analysts
50
Total ratings
21.28%
Success rate
-13.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VERA Vera Therapeutics | Maintains: Overweight | 107 100 | 18.94 | 427.98% | 8 | May 7, 2025 | |
VYGR Voyager Therapeutics | Reiterates: Overweight | n/a | n/a | n/a | 2 | Mar 12, 2025 | |
ARCT Arcturus Therapeutic... | Reiterates: Overweight | n/a | n/a | n/a | 6 | Mar 7, 2025 | |
PLRX Pliant Therapeutics | Reinstates: Neutral | n/a | n/a | n/a | 5 | Mar 4, 2025 | |
KALV KalVista Pharma | Reiterates: Overweight | n/a | n/a | n/a | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 | 4.11 | 21.65% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 | 1.02 | 1174.51% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 | n/a | n/a | 2 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | 8.76 | -8.68% | 1 | Mar 20, 2023 |